Research at MD Anderson
Research with one goal: end cancer
At MD Anderson, some of the best minds in the world work in partnership with our patients to enable groundbreaking research to better treat and prevent cancer. Here, researchers have the freedom and support to follow a hypothesis and test new theories that can yield breakthroughs that transform the field and the lives of patients. Embedded in the fourth-largest U.S. city — and the most ethnically diverse — our teams work with our neighbors in the Texas Medical Center, the world’s largest medical center, and around the globe to advance our science and to serve our patients. From the first spark of an idea to its translation in our world-leading clinics, we remain invested and determined in our collective focus to end cancer.
Departments, Labs and Institutes
MD Anderson has many parts, including departments, labs and institutes, but the sum of those parts is ending cancer.
Our laboratories cover the full breadth of cancer research. They’re led by some of the leading scientists and physicians in the world.
Scientists from different disciplines come together to focus on a common area in our research institutes.
A sense of community
Katy Rezvani, M.D., Ph.D.
Professor, Department of Stem Cell Transplantation
Director of Translational Research
There is a sense of community in terms of ‘let’s come together and develop treatments for our patients that could be life-changing.'
Vaccine against relapse
A new era to end cancer
Oral leukemia treatment
Breast cell atlas
Faculty elected to NAM
Lung cancer treatment
CAR NK cell therapy
MD Anderson at SSO
At the Society of Surgical Oncology 2024 meeting, our experts join other leading minds in surgical oncology to discuss the latest practice-changing surgical innovations that will benefit patients from across the globe.
Research by the Numbers
invested in research
patents awarded to MD Anderson in FY23
in funding from the Cancer Prevention Research Institute of Texas (CPRIT) in FY23
MD Anderson's research and training are also aided by more than $172 million in NIH grant funding, which helps power our mission to end cancer.View our NIH award summary
Explore the work of our investigators
MD Anderson faculty focus on a variety of research topics that contribute to our goal of ending cancer.